Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Cephalon (UK) Limited
Teva UK Limited, Field House, Station Approach, Harlow, Essex, CM20 2FB
Telephone: +44 (0) 207 5407117
Fax: +44 (0) 207 4507349
WWW: http://www.tevauk.com
Medical Information Direct Line: +44 (0) 207 5407117
Medical Information e-mail: medinfo@tevauk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 11/06/2010
PIL Zelapar

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/06/2010 and displayed until Current
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 08/01/2009 and displayed until 11/06/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 28/10/2008 and displayed until 08/01/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 17/07/2008 and displayed until 28/10/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to name of manufacturer
  • Change to MA holder contact details
Updated on 03/06/2008 and displayed until 17/07/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 01/08/2006 and displayed until 03/06/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 30/04/2001 and displayed until 01/08/2006
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  selegiline hydrochloride